A detailed history of U.S. Capital Wealth Advisors, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, U.S. Capital Wealth Advisors, LLC holds 9,093 shares of ZTS stock, worth $1.61 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
9,093
Previous 9,423 3.5%
Holding current value
$1.61 Million
Previous $1.63 Million 8.76%
% of portfolio
0.07%
Previous 0.07%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$172.58 - $196.48 $56,951 - $64,838
-330 Reduced 3.5%
9,093 $1.78 Million
Q2 2024

Jul 11, 2024

SELL
$145.54 - $178.83 $39,295 - $48,284
-270 Reduced 2.79%
9,423 $1.63 Million
Q1 2024

May 10, 2024

SELL
$165.67 - $199.94 $32,636 - $39,388
-197 Reduced 1.99%
9,693 $1.64 Million
Q4 2023

Feb 06, 2024

SELL
$151.44 - $200.09 $18,172 - $24,010
-120 Reduced 1.2%
9,890 $1.95 Million
Q3 2023

Oct 19, 2023

SELL
$167.14 - $192.77 $38,776 - $44,722
-232 Reduced 2.27%
10,010 $1.74 Million
Q2 2023

Aug 04, 2023

SELL
$160.94 - $186.23 $6,437 - $7,449
-40 Reduced 0.39%
10,242 $1.76 Million
Q1 2023

May 11, 2023

BUY
$145.48 - $175.02 $27,204 - $32,728
187 Added 1.85%
10,282 $1.71 Million
Q4 2022

Feb 03, 2023

BUY
$131.14 - $157.47 $18,884 - $22,675
144 Added 1.45%
10,095 $1.48 Million
Q3 2022

Nov 01, 2022

BUY
$148.29 - $182.55 $645,654 - $794,822
4,354 Added 77.79%
9,951 $1.48 Million
Q2 2022

Aug 12, 2022

SELL
$155.97 - $200.09 $157,529 - $202,090
-1,010 Reduced 15.29%
5,597 $962,000
Q1 2022

May 12, 2022

SELL
$181.39 - $234.03 $1,813 - $2,340
-10 Reduced 0.15%
6,607 $1.25 Million
Q4 2021

Jan 21, 2022

SELL
$193.69 - $247.03 $11,427 - $14,574
-59 Reduced 0.88%
6,617 $1.62 Million
Q3 2021

Nov 01, 2021

BUY
$189.29 - $209.69 $1.26 Million - $1.4 Million
6,676 New
6,676 $1.3 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track U.S. Capital Wealth Advisors, LLC Portfolio

Follow U.S. Capital Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of U.S. Capital Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on U.S. Capital Wealth Advisors, LLC with notifications on news.